4//SEC Filing
Glessner Coleen 4
Accession 0001367644-23-000070
CIK 0001367644other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 7:36 PM ET
Size
9.3 KB
Accession
0001367644-23-000070
Insider Transaction Report
Form 4
Glessner Coleen
EVP, Quality & Ethics, and CPL
Transactions
- Award
Common Stock
2023-03-02+3,846→ 111,982 total - Award
Common Stock
2023-03-02+7,692→ 119,674 total - Award
Employee Stock Options (Right to Buy)
2023-03-02+7,692→ 31,343 totalExercise: $12.06Exp: 2030-03-01→ Common Stock (7,692 underlying)
Footnotes (4)
- [F1]Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in two equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- [F2]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
- [F3]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
- [F4]Represents the corrected number of securities owned due to a computational error on prior Form-4.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001919170
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 7:36 PM ET
- Size
- 9.3 KB